| Literature DB >> 32393271 |
Zahra Rahmati1,2, Saeed Behzadipour3,4, Alfred C Schouten5,6, Ghorban Taghizadeh7, Keikhosrow Firoozbakhsh1.
Abstract
BACKGROUND: Balance training improves postural control in Parkinson's disease (PD). However, a systematic approach for the development of individualized, optimal training programs is still lacking, as the learning dynamics of the postural control in PD, over a training program, are poorly understood.Entities:
Keywords: Learning dynamics; Parkinson’s disease; Pattern of improvement; Postural control model; Stability and flexibility degree
Mesh:
Year: 2020 PMID: 32393271 PMCID: PMC7216342 DOI: 10.1186/s12938-020-00776-1
Source DB: PubMed Journal: Biomed Eng Online ISSN: 1475-925X Impact factor: 2.819
Clinical outcomes of patients with PD at pre-, mid-, and post-training
| Clinical measure | PD patients (n = 20) | ANOVA | Effect size | Tukey | Change pattern | ||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-training | Mid-training | Post-training | Pre to mid | Mid to post | Pre to post | ||||
| Functional balance | |||||||||
| Functional reach test (cm) | 23.5 ± 7.9 | 32.8 ± 6.7* | 37.6 ± 6.1†* | 0.694 | Continuous | ||||
| Step test (taps in 15 s) | 13.2 ± 3.5 | 15.9 ± 4.0* | 17.3 ± 3.6* | 0.557 | 0.063 | Saturation | |||
| Tinetti balance score | 14.7 ± 1.5 | 15.6 ± 0.9* | 15.9 ± 0.2* | 0.332 | 0.320 | Saturation | |||
| Tandem stancea—EO (s) | 93.0 ± 27.6 | 113.7 ± 12.6* | 118.3 ± 5.7* | 0.433 | 0.141 | Saturation | |||
| Tandem stancea—EC (s) | 35.4 ± 26.8 | 54.8 ± 29.1* | 72.7 ± 30.2†* | 0.549 | Continuous | ||||
| Functional mobility | |||||||||
| TUG (s) | 9.1 ± 2.7 | 7.4 ± 1.6* | 6.5 ± 1.4*† | 0.553 | Continuous | ||||
| 6MWT (m) | 226.0 ± 67 | 254.1 ± 61* | 305.5 ± 62*† | 0.510 | Continuous | ||||
| Tinetti gait score | 10.5 ± 1.4 | 11.5 ± 0.6* | 11.8 ± 0.4*† | 0.422 | Continuous | ||||
Values are reported as mean ± standard deviation
EO, eyes open; EC, eyes closed; TUG, Timed Up and Go test; 6MWT, Six-minute walk test; FRT, Functional reach test; Continuous, continuously improving with significant difference between all time points; Saturation, improvements with saturation at the end—i.e., significant change in the first half of the training (from pre- to mid-training), but then non-significant from mid- to post-training points
Post-hoc Tukey tests for pairwise comparisons between time points: *significantly different from pre-training (P < 0.05); †significantly different from mid-training (P < 0.05)
Significant P values are in italic
aTimed tandem stance was performed with the right and left leg in the front position, and then the time of both legs was summed as one scale (with maximum score of 120 s, considering that the maximum time to complete each stance test was set to 60 s)
Sway measures (RMS, MV, f95, ∆t) and model parameters (K, K, K, K, τ) of patients with PD, at pre-, week 2, week 4, and post-training, in R-tasks (RO: stance on rigid surface with eyes open, and RC: stance on rigid surface with eyes closed)
| Task | PD patients ( | ANOVA | Effect size | Tukey | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sway measures/model parameters | Pre ( | Week 2 (T2) | Week 4 (T3) | Post (T4) | ||||||||
| RO | ||||||||||||
| | 5.99 ± 1.80 | 7.21 ± 2.90 | 6.78 ± 2.38 | 6.56 ± 1.98 | 0.186 (1.66) | 0.080 | 0.346 | 0.562 | 0.381 | 0.842 | 0.716 | 0.970 |
| | 10.04 ± 3.25 | 10.22 ± s3.75 | 11.20 ± 3.41 | 12.31 ± 4.30† | 0.179 | 0.994 | 0.468 | 0.052 | 0.266 | 0.541 | ||
| | 1.14 ± 0.39 | 1.12 ± 0.35 | 1.26 ± 0.42 | 1.37 ± 0.58 | 0.106 (2.13) | 0.101 | 0.998 | 0.712 | 0.243 | 0.373 | 0.260 | 0.792 |
| ∆ | 1.59 ± 0.54 | 1.75 ± 0.57 | 1.70 ± 0.41 | 1.76 ± 0.49 | 0.531 (0.742) | 0.038 | 0.686 | 0.821 | 0.452 | 0.983 | 1.000 | 0.935 |
| | 16.43 ± 3.78 | 16.84 ± 3.65 | 16.96 ± 3.51 | 18.42 ± 4.88 | 0.062 (2.58) | 0.120 | 0.958 | 0.750 | 0.192 | 0.998 | 0.079 | 0.383 |
| | 5.87 ± 1.84 | 5.22 ± 1.93 | 5.47 ± 1.54 | 5.94 ± 2.20 | 0.370 (1.07) | 0.053 | 0.309 | 0.802 | 1.000 | 0.931 | 0.372 | 0.788 |
| | 1.46 ± 0.82 | 1.09 ± 0.74 | 1.56 ± 0.65 | 1.31 ± 0.76 | 0.125 (2.00) | 0.095 | 0.192 | 0.971 | 0.916 | 0.187 | 0.690 | 0.436 |
| | 446.9 ± 215 | 462.3 ± 214 | 543.3 ± 211 | 568.9 ± 197* | 0.155 | 0.989 | 0.278 | 0.132 | 0.085 | 0.956 | ||
| | 135.3 ± 33.0 | 115.7 ± 44.0 | 117.1 ± 28.6 | 109.3 ± 28.5 | 0.059 (2.63) | 0.122 | 0.339 | 0.294 | 0.058 | 0.999 | 0.914 | 0.768 |
| RC | ||||||||||||
| | 6.64 ± 2.11 | 7.13 ± 3.09 | 7.23 ± 2.42 | 6.63 ± 2.10 | 0.463 (0.868) | 0.044 | 0.827 | 0.428 | 1.000 | 0.998 | 0.850 | 0.201 |
| | 11.94 ± 5.37 | 11.73 ± 5.37 | 13.81 ± 5.08 | 14.92 ± 6.12* | 0.140 | 0.999 | 0.109 | 0.360 | 0.216 | 0.725 | ||
| | 1.37 ± 0.51 | 1.47 ± 0.53 | 1.56 ± 0.52 | 1.74 ± 0.70 | 0.085 (2.31) | 0.109 | 0.802 | 0.472 | 0.215 | 0.903 | 0.389 | 0.599 |
| ∆ | 1.51 ± 0.59 | 1.22 ± 0.37 | 1.23 ± 0.35 | 1.34 ± 0.47 | 0.093 (2.24) | 0.105 | 0.180 | 0.246 | 0.676 | 0.998 | 0.780 | 0.637 |
| | 19.64 ± 6.57 | 18.91 ± 4.62 | 19.49 ± 5.91 | 21.13 ± 5.53 | 0.148 (1.85) | 0.089 | 0.874 | 0.999 | 0.354 | 0.914 | 0.061 | 0.474 |
| | 6.06 ± 2.26 | 5.84 ± 1.28 | 6.45 ± 1.72 | 6.69 ± 2.12 | 0.110 (2.10) | 0.100 | 0.958 | 0.637 | 0.463 | 0.214 | 0.199 | 0.865 |
| | 1.83 ± 1.37 | 1.60 ± 0.87 | 1.66 ± 0.94 | 2.05 ± 1.09 | 0.264 (1.36) | 0.067 | 0.831 | 0.934 | 0.866 | 0.991 | 0.166 | 0.199 |
| | 547.1 ± 314 | 568.8 ± 303 | 652.1 ± 321 | 718.0 ± 344 | 0.139 | 1.000 | 0.575 | 0.120 | 0.238 | 0.071 | 0.486 | |
| | 121.9 ± 40.4 | 129.8 ± 40.3 | 127.6 ± 38.1 | 117.0 ± 41.1 | 0.428 (0.939) | 0.047 | 0.876 | 0.907 | 0.929 | 0.993 | 0.456 | 0.290 |
Values are reported as mean ± standard deviation. Significant P values are in italics
T1 to T4 refer to pre-, week 2, week 4, and post-training, respectively
* Significantly different from pre-training (P < 0.05); †significantly different from week 2 (P < 0.05)
Sway measures (RMS, MV, f95, ∆t) and model parameters (K, K, K, K, τ) of patients with PD, at pre-, week 2, week 4, and post-training, in F-tasks (FO: stance on foam with eyes open, and FC: stance on foam with eyes closed)
| Task | PD patients ( | ANOVA | Effect size | Tukey | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sway measures/model parameters | Pre ( | Week 2 ( | Week 4 ( | Post ( | ||||||||
| FO | ||||||||||||
| 10.72 ± 2.89 | 9.20 ± 2.47 | 9.73 ± 2.21 | 9.37 ± 1.98 | 0.134 | 0.105 | 0.397 | 0.227 | 0.674 | 0.987 | 0.840 | ||
| 19.80 ± 6.52 | 19.17 ± 6.30 | 19.89 ± 5.82 | 18.51 ± 4.70 | 0.616 (0.603) | 0.031 | 0.944 | 1.000 | 0.631 | 0.933 | 0.937 | 0.629 | |
| 1.05 ± 0.24 | 1.12 ± 0.22 | 1.31 ± 0.33*† | 1.32 ± 0.35* | 0.299 | 0.549 | 0.059 | 0.996 | |||||
| ∆ | 1.58 ± 0.44 | 1.43 ± 0.45 | 1.21 ± 0.25* | 1.31 ± 0.28* | 0.220 | 0.648 | 0.116 | 0.666 | 0.308 | |||
| 18.52 ± 4.34 | 18.69 ± 5.21 | 20.49 ± 5.78 | 19.75 ± 5.21 | 0.156 | 0.992 | 0.123 | 0.276 | 0.237 | 0.397 | 0.299 | ||
| 5.23 ± 1.65 | 5.12 ± 1.46 | 5.34 ± 1.17 | 5.49 ± 1.33 | 0.602 (0.625) | 0.032 | 0.990 | 0.990 | 0.844 | 0.824 | 0.088 | 0.868 | |
| 1.93 ± 1.21 | 1.96 ± 1.36 | 1.88 ± 0.82 | 1.89 ± 1.17 | 0.986 (0.048) | 0.003 | 1.000 | 0.992 | 0.999 | 0.983 | 0.995 | 1.000 | |
| 803.6 ± 262 | 787.5 ± 259 | 804.8 ± 172 | 817.5 ± 208 | 0.920 (0.164) | 0.009 | 0.988 | 1.000 | 0.983 | 0.981 | 0.934 | 0.980 | |
| 134.8 ± 34.8 | 125.1 ± 27.2 | 123.8 ± 31.7 | 111.9 ± 23.8 | 0.142 | 0.554 | 0.680 | 0.072 | 0.998 | 0.053 | 0.295 | ||
| FC | ||||||||||||
| 14.14 ± 2.83 | 13.40 ± 3.34 | 12.46 ± 2.33* | 12.40 ± 2.81* | 0.170 | 0.636 | 0.532 | 0.427 | 0.999 | ||||
| 29.15 ± 7.83 | 26.56 ± 7.57 | 28.07 ± 8.34 | 26.40 ± 7.22 | 0.096 (2.22) | 0.105 | 0.128 | 0.845 | 0.171 | 0.548 | 0.999 | 0.670 | |
| 1.23 ± 0.34 | 1.21 ± 0.24 | 1.42 ± 0.34† | 1.44 ± 0.43 | 0.234 | 0.974 | 0.065 | 0.106 | 0.076 | 0.988 | |||
| ∆ | 1.43 ± 0.40 | 1.27 ± 0.26 | 1.18 ± 0.17 | 1.11 ± 0.15* | 0.258 | 0.221 | 0.061 | 0.488 | 0.091 | 0.576 | ||
| 18.82 ± 4.43 | 18.69 ± 5.10 | 20.34 ± 4.82* | 20.12 ± 5.30 | 0.130 | 0.999 | 0.105 | 0.277 | 0.415 | 0.971 | |||
| 5.17 ± 1.54 | 5.29 ± 1.93 | 5.27 ± 1.57 | 5.80 ± 1.43 | 0.120 (2.03) | 0.097 | 0.950 | 0.967 | 0.051 | 1.000 | 0.580 | 0.256 | |
| 2.14 ± 1.19 | 2.14 ± 1.08 | 1.97 ± 1.07 | 2.51 ± 1.54 | 0.317 (1.20) | 0.060 | 1.000 | 0.935 | 0.614 | 0.934 | 0.652 | 0.248 | |
| 1273 ± 499 | 1113 ± 493 | 1153 ± 415 | 1145 ± 372 | 0.298 (1.26) | 0.062 | 0.510 | 0.290 | 0.608 | 0.967 | 0.969 | 1.000 | |
| 122.8 ± 37.8 | 124.6 ± 62.8 | 125.1 ± 48.5 | 125.1 ± 46.5 | 0.994 (0.026) | 0.001 | 0.998 | 0.996 | 0.995 | 1.000 | 1.000 | 1.000 | |
Values are reported as mean ± standard deviation. Significant P values are in italics
T1 to T4 refer to pre-, week 2, week 4, and post-training, respectively
*Significantly different from pre-training (P < 0.05); †significantly different from week 2 (P < 0.05)
Fig. 1The pattern of improvements for sway measures (RMS, MV, f95, ∆t) and model parameters (K, K, τ) for patients with PD, at four time points (i.e., pre-, week 2, week 4, and post-training) during the balance-training program, in tasks with stance on rigid surface with eyes open (RO), and eyes closed (RC). Significant measures are in bold. Tukey P values are reported for post-hoc pairwise comparisons. The first time point, at which significant change appeared, and further time points, if that level of improvement retained, are marked with asterisk
Fig. 2The pattern of improvements for sway measures (RMS, MV, f95, ∆t) and model parameters (K, K, τ) for patients with PD, at four time points (i.e., pre-, week 2, week 4, and post-training) during the balance-training program, in tasks with stance on foam with eyes open (FO) and eyes closed (FC). Significant measures are in bold. Tukey P values are reported for post-hoc pairwise comparisons. The first time point, at which significant change appeared, and further time points, if that level of improvement retained, are marked with asterisk
Patients’ characteristics
| Characteristic | PD patients ( |
|---|---|
| Mean ± standard deviation | |
| Age (years) | 63.3 ± 7.5 |
| Gender (male:female) | 15: 5 |
| Height (m) | 1.67 ± 0.08 |
| Weight (kg) | 69.7 ± 14.7 |
| Disease duration (years) | 8.15 ± 4.8 |
| Most affected side (right:left) | 14: 6 |
| Disease severity (Hoehn and Yahr) | 1.8 ± 0.7 |
| Medications | |
| Madopar/Levodopa, No. (%) | 20 (100) |
| Dopamine agonists, No. (%) | 6 (30) |
| Antidepressants, No (%) | 4 (20) |
| Benzodiazepines, No (%) | 3 (15) |
Fig. 3The patient-specific postural control model of PD. The model consisted of human ‘Body’, CNS in form of a PID controller, and time delay (τ). The ‘Body’ was modeled by an inverted pendulum with all mass (m) centered at the height of h (which were adjusted patient-specifically). J, moment of inertia of body around ankle axis. The COP displacement (y) was calculated from the body sway angle (θ) considering the feet mass (m = 2.01 kg), which is fully described in [37]. The CNS was modeled by a PID controller: K (proportional gain—quantifies the stability degree), K (derivative gain), K (integral gain). T, corrective ankle torque; T, disturbance torque; K, internal disturbance torque gain which quantifies the flexibility degree; τ = 100 s, time constant for low-pass filter
The balance-training program
| Week | Dist. level* | Exercises with | Overground balance exercises and conventional exercises | ||
|---|---|---|---|---|---|
| Limit of stability (LOS)a | Random controlc | Postural stabilitye | |||
| 1–2 | No Dist. | Size: 1–5 distance: 1–3 | Size: 1–5 Speed: 1–4 | Week 1: – Week 2: Dist1 | Stance on rigid surface with combination of these conditions (from easier to more difficult): Eyes open/eyes closed Semi-tandem/tandem/one-leg With ball in hands Walking: In tandem gait with eyes open and closed, Forward, backward, sideways, Step around and over obstacles Combined with sit-to-stand-up |
| 3–4 | Dist1 | Size: 1–5 Distance: 1–3 | Size: 1–5 Speed: 1–4 | Week 3: Dist 1 week 4: Dist 2 | |
Standing on foam with combination of these conditions (from easier to more difficult): Eyes open/eyes closed Tandem/one-leg/one-leg and rolling a rod, turning a rod, or writing their name, or rhythmically tap a step of 7.5 cm height with other leg With ball in hands, throwing ball to different directions, given shoulder pulls by the trainer, rotating head and the trunk, squat Combined with sit-to-stand-up Walking: Combined with sit-to-stand-up Crossing obstacles, kicking a ball, with ball in hands, throwing ball to different directions, rotating head and the trunk | |||||
| 5–6 | Dist 2 | Size: 1–5 Distance: 1–3 | Size: 1–5 Speed: 1–4 | Week 5: Dist 2 week 6: - | |
aLOS exercise repetitions in each session: 3–7 rep
bTarget sizes: 1–5 (size 1 is the largest target circle, and size 5 the smallest target circle); Target distances: 1–3 (distance 1 is the nearest distance at 50% of each patient’s maximum forward lean; distance 2 is at 80% of each patient’s maximum forward lean; and distance 3 is at 100% of each patient’s maximum forward lean. Distances were pre-calibrated and set according to each patient’s maximum forward lean at the beginning of each session
cRandom Control exercise repetitions in each session: 2–3 rep
dCircle sizes: 1–5 (size 1 is the largest circle size, and size 5 the smallest circle size); Circle speed: 1–4 (speed 1 is the slowest, and speed 4 is the fastest almost affordable speed)
ePostural Stability exercise repetitions in each session: 2–3 rep. The Postural Stability exercise was performed on the random tilt disturbances of support surface in anterior–posterior direction, either with setting Dist1 or Dist2 as described below
* Two exercises with Balance Robot, i.e., Limit of Stability (LOS) and Random Control were performed on an stationary support surface (‘No Disturbance’) during weeks 1–2, or on the disturbing support surface with two levels of ‘Dist1’, and ‘Dist2’, during weeks 3–6. The disturbances were in the form of random-amplitude and random-speed sequences of tilt motions in the anterior–posterior direction. The amplitude was randomly set in the range of 1° to 7° in Dist1, and 2° to 11° in Dist2. The speed was also randomly selected from the range of 1 deg/s to 10 deg/s in Dist1 and to 15 deg/s in Dist2